Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
32
EDAP Quote, Financials, Valuation and Earnings
Last price:
$2.30
Seasonality move
:
-1.53%
Day range:
$2.20 - $2.35
52-week range:
$2.00 - $8.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.23x
P/B ratio:
1.77x
Volume:
45.3K
Avg. volume:
36.8K
1-year change:
-69.2%
Market cap:
$84.2M
Revenue:
$65.4M
EPS (TTM):
-$0.63
Analysts' Opinion
-
Consensus RatingEdap TMS SA has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.67, Edap TMS SA has an estimated upside of 369.9% from its current price of $2.27.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $2.27.
Fair Value
-
According to the consensus of 1 analyst, Edap TMS SA has 369.9% upside to fair value with a price target of $10.67 per share.
EDAP vs. S&P 500
-
Over the past 5 trading days, Edap TMS SA has underperformed the S&P 500 by -8.55% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Edap TMS SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Edap TMS SA has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Edap TMS SA reported revenues of $14.4M.
Earnings Growth
-
Edap TMS SA earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Edap TMS SA reported earnings per share of -$0.19.
Enterprise value:
60M
EV / Invested capital:
--
Price / LTM sales:
1.23x
EV / EBIT:
--
EV / Revenue:
0.87x
PEG ratio (5yr expected):
-2.21x
EV / Free cash flow:
-2.40x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$28.2M
Return On Assets:
-25.41%
Net Income Margin (TTM):
-34.94%
Return On Equity:
-42.5%
Return On Invested Capital:
-39.29%
Operating Margin:
-44.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $58M | $60.3M | $68.7M | $12.8M | $14.4M | |
| Gross Profit | $25.2M | $24.6M | $28.2M | $4.5M | $5.7M | |
| Operating Income | -$2.2M | -$19.3M | -$22M | -$6M | -$6.4M | |
| EBITDA | $706.6K | -$16.9M | -$22.5M | -$6M | -$6.4M | |
| Diluted EPS | $0.11 | -$0.62 | -$0.63 | -$0.12 | -$0.19 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $48.8M | $75M | $92.4M | $85M | $71.4M | |
| Total Assets | $60.6M | $85.5M | $103M | $98.7M | $88.3M | |
| Current Liabilities | $22.4M | $17.3M | $21.2M | $27.5M | $32.8M | |
| Total Liabilities | $31.1M | $29.7M | $30M | $35.1M | $40.7M | |
| Total Equity | $29.5M | $55.7M | $73M | $63.6M | $47.6M | |
| Total Debt | $3.1M | $7.7M | $5.2M | $4.3M | $4.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.8M | -$18M | -$21M | -$1.7M | -$5.6M | |
| Cash From Investing | -$20.7M | $13.6M | -$4M | -$917.8K | -$1.1M | |
| Cash From Financing | $21.5M | $4.7K | -$520.6K | -$454.8K | $642.2K | |
| Free Cash Flow | $4.2M | -$22.5M | -$25M | -$2.6M | -$6.7M | |
EDAP
Sector
Market Cap
$84.2M
$37.4M
Price % of 52-Week High
26.71%
45.61%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
-69.2%
-38.36%
Beta (5-Year)
0.372
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.41
200-day SMA
Sell
Level
$3.38
Bollinger Bands (100)
Sell
Level
2.23 - 2.67
Chaikin Money Flow
Sell
Level
-43.8M
20-day SMA
Sell
Level
$2.55
Relative Strength Index (RSI14)
Sell
Level
36.50
ADX Line
Buy
Level
29.25
Williams %R
Buy
Level
-87.8599
50-day SMA
Sell
Level
$2.41
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
78.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.696)
Sell
CA Score
(Annual)
Level (-0.4008)
Buy
Beneish M-Score
(Annual)
Level (-2.5418)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.1343)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
Stock Forecast FAQ
In the current month, EDAP has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EDAP average analyst price target in the past 3 months is $10.67.
-
Where Will Edap TMS SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Edap TMS SA share price will rise to $10.67 per share over the next 12 months.
-
What Do Analysts Say About Edap TMS SA?
Analysts are divided on their view about Edap TMS SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Edap TMS SA is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Edap TMS SA's Price Target?
The price target for Edap TMS SA over the next 1-year time period is forecast to be $10.67 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EDAP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Edap TMS SA is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of EDAP?
You can purchase shares of Edap TMS SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Edap TMS SA shares.
-
What Is The Edap TMS SA Share Price Today?
Edap TMS SA was last trading at $2.30 per share. This represents the most recent stock quote for Edap TMS SA. Yesterday, Edap TMS SA closed at $2.27 per share.
-
How To Buy Edap TMS SA Stock Online?
In order to purchase Edap TMS SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
